TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...
From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...
MinIO, the data foundation for enterprise analytics and AI, is debuting AIStor Table Sharing, a capability built into MinIO AIStor that allows enterprises to securely share their on-premises data ...
Show the world that you have the foundational knowledge regulatory affairs professionals need. The new Foundation in Regulatory Affairs (FRA) assessment-based certificate is designed to help you build ...
Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi and protozoa. This discipline includes fundamental research on the biochemistry, physiology, cell biology, ...
Too many digital twin initiatives stall after the pilot phase, failing to deliver real business impact. Without a trusted data foundation, companies risk costly downtime, inaccurate predictions, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results